CTX Lifescience Pvt Ltd
PMDA      
US FDA INSPECTED & COMPLIANT   
EU GMP CERTIFIED   
PMDA JAPAN ACCREDITATION   
Pharma Products
 
API - Under Development
Sr. No Product Name Therapeutic Category R & D Sample Method Devp Validation Status
1. Alogliptin Benzoate Anti-diabetic Q1 2019
2. Brexpiprazole Anti-schizophrenic Q2 2019
3. Chlorthalidone Anti - hypertensives     Q2 2019
4. Linagliptin Anti-diabetic     Q4 2019
5. Ticagrelor Anti-coagulant     Q4 2019
CTX Life Sciences Pvt. Ltd. respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API / Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.